Status:
COMPLETED
Effects of Breast Milk Simulated Infant Formula
Lead Sponsor:
Sun Yat-sen University
Conditions:
Infant Formula
Breast Milk
Eligibility:
All Genders
Up to 30 years
Phase:
NA
Brief Summary
Objective：The aim of this trial is to assess effects of Kieember and Yashili infant formula on body growth, behavior development, intestinal comfort, infectious diseases, allergic diseases, the absorp...
Eligibility Criteria
Inclusion
- Term infant: Born at 37-42 gestation weeks
- Birth weight: 2500-4000g (appropriate for gestational age)
- The infant is in good health and Apgar after 5 minutes \>7
- The mother had unequivocally decided not to breastfeed (for formula fed infants) or to breastfeed (for human milk fed infants)
- age at the enrollment: less than 30 days
Exclusion
- The mother is unable to take care of her infant on account of health condition (psychological or physical) or socioeconomic problems
- The infant is born with a congenital malformation or chromosome abnormality with a clinical significance
- The infant suffers from a disease requiring mechanical ventilation or medication in the first week of life (not including applying phototherapy of blue to cure neonatal jaundice)
- The infant whose feeding or normal metabolism is affected by any suspected or unknown metabolic factors or physical limitations
- The infant has been breastfed for more than 2 weeks (for formula fed infants)
- Twins or multiple births
Key Trial Info
Start Date :
April 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 25 2023
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT05295030
Start Date
April 10 2022
End Date
December 25 2023
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University
Guangzhou, Guangdong, China, 510080